Table 3.
GRS (-) | n= 15 | P value |
Treatment | ||
BRTO | 6 (40) | NS |
PTO | 5 (33) | NS |
CA | 4 (27) | NS |
Early recurrence rate within 6 mo | ||
BRTO | 1 (16.7) | |
PTO | 2 (40) | |
CA | 2 (50) |
BRTO: Balloon-occluded retrograde transvenous obliteration; PTO: Percutaneous transhepatic obliteration; CA: Endoscopic injection sclerotherapy using α-cyanoacrylate glue; GRS: Gastro-renal shunt.